Contact this trialFirst, we need to learn more about you.
Anti-metabolites
MTX101 for Migraine
Recruiting0 awardsPhase 2
La Jolla, California
This trial aims to determine if the drug MTX101 is effective in treating acute migraine attacks in adults and to assess its safety. Participants will take either MTX101 or a placebo for one migraine attack with each treatment. They will visit the clinic twice and have one phone call over a 4-week period for checkups and tests. Researchers will compare the effectiveness of MTX101 to a placebo in reducing headache pain and the need for rescue medication, as well as monitor any side effects experienced by participants.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service